Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,740 | -$39,426 | -$32,543 | -$33,641 |
| Dep. & Amort. | $214 | $210 | $194 | $180 |
| Deferred Tax | $1,057 | $576 | $576 | $576 |
| Stock-Based Comp. | $10,836 | $11,840 | $6,617 | $3,906 |
| Change in WC | $0 | -$1,685 | -$4,006 | $240 |
| Other Non-Cash | $1,080 | $284 | $102 | $378 |
| Operating Cash Flow | -$26,553 | -$28,201 | -$29,060 | -$28,361 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$5,750 | -$5,000 | $0 | $0 |
| Investing Cash Flow | -$5,750 | -$5,000 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $27 | $13,804 | $13,798 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $33,303 | -$3,831 | $31 | $0 |
| Financing Cash Flow | $33,303 | $9,972 | $13,829 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,000 | -$23,229 | -$15,231 | -$28,361 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,252 | $26,481 | $41,712 | $70,073 |
| End Cash | $4,252 | $3,252 | $26,481 | $41,712 |
| Free Cash Flow | -$26,553 | -$28,201 | -$29,060 | -$28,361 |